Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 71 - 80 out of 88

AMIA Testifies before ONC's Privacy & Security Tiger Team

December 9, 2010

AMIA’s testimony examines patient data matching before ONC’s Privacy & Security Tiger Team. AMIA's Brad Malin discusses some concerns of the accuracy in patient matching and the implications of misidentified data in patient care and biomedical research, which could lead to false match or false non-match.

AMIA Board Position on Ethics: Vendor Values, Patient Safety and Best Practices

November 12, 2010

The current commercial health information technology (IT) arena encompasses a number of competing firms that provide electronic health applications to hospitals, clinical practices, and other healthcare-related entities. Such applications collect, store, and analyze patient information. Some vendors incorporate contract language whereby purchasers of health IT systems, such as hospitals and […]

AMIA Submits Comments to DEA on E-Prescribing Controlled Substances

May 29, 2010

AMIA comments to DEA on E-Prescribing Controlled Substances which would revise the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Controlled Substances Act, or CSA) and the related regulations to allow healthcare providers to write prescriptions for controlled substances electronically. These revisions would have to allow e-prescribing controlled substances […]

AMIA Testimony to HIT Policy Committee on Patient Safety and HIT

February 25, 2010

AMIA’s testimony to the HIT Policy Committee, Adoption/Certification Workgroup, discusses potential unintended consequences of health information technology (HIT) and HIT policy, as well as effective options for addressing them. AMIA and its task force offer several recommendations that involve unintended consequences and conjure questions from previous observations in identifying safety […]

AMIA Comments on HIPAA Enforcement Interim Rule

December 24, 2009

AMIA comments on the interim final rule, which amends the enforcement regulations promulgated under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) to conform to the revisions made pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH) for which the Secretary may impose a […]

AMIA Comments on Genetic Information Nondiscrimination Act of 2008 (GINA)

December 4, 2009

AMIA comments on the proposed rule to the Genetic Information Nondiscrimination Act of 2008 (GINA). AMIA supports the inclusion in the HIPAA Privacy Rule to prohibit against the use of genetic information for underwriting purposes. Covered entities (CE) would use genetic information only to benefit the individual and not for […]